Epstein Secrets

C World News Tonight <https://playvideo.bulletinintelligence.corn/bf8faa812b484ed0b4f6c615238318a67pubid=fbi> (11/15, story 2, 2:15, Llamas, 4.5M), Elwyn Lopez reported Pfizer, "the first drug maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as ea

sweeping, or made to harass or embarrass the president." The New York Times <https://vvww.nytimes.com/2020/11/13/nyregion/trump-taxes.html> (11/13, Rashbaum, Weiser, 18.61M) says the President "lost more than an election last week," and "when he leaves the White House in January, he will also lose the c

er Could Apply For FDA's Emergency Authorization Of Vaccine As Soon As This Week. On ABC World News TonightVI (11/15, story 2, 2:15, Llamas, 4.5M), Elwyn Lopez reported Pfizer, "the first drug maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as e

banks and Trump's longtime accounting firm Mazars USA were too sweeping, or made to harass or embarrass the president." The New York Times (11/13, Rashbaum, Weiser, 18.61M) says the President "lost more than an election last week," and "when he leaves the White House in January, he will also lose the c

er Could Apply For FDA's Emergency Authorization Of Vaccine As Soon As This Week. On ABC World News TonightVI (11/15, story 2, 2:15, Llamas, 4.5M), Elwyn Lopez reported Pfizer, "the first drug maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as e

banks and Trump's longtime accounting firm Mazars USA were too sweeping, or made to harass or embarrass the president." The New York Times (11/13, Rashbaum, Weiser, 18.61M) says the President "lost more than an election last week," and "when he leaves the White House in January, he will also lose the c

er Could Apply For FDA's Emergency Authorization Of Vaccine As Soon As This Week. On ABC World News TonightVI (11/15, story 2, 2:15, Llamas, 4.5M), Elwyn Lopez reported Pfizer, "the first drug maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as e

banks and Trump's longtime accounting firm Mazars USA were too sweeping, or made to harass or embarrass the president." The New York Times (11/13, Rashbaum, Weiser, 18.61M) says the President "lost more than an election last week," and "when he leaves the White House in January, he will also lose the c